Kazia Therapeutics Ltd - Company Profile
Powered by 
All the data and insights you need on Kazia Therapeutics Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Kazia Therapeutics Ltd Strategy Report
- Understand Kazia Therapeutics Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Kazia Therapeutics Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Kazia Therapeutics Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
John Friend, MD
Chief Executive Officer; Chairman - Interim; Managing Director Executive BoardMr. John Friend has been the Interim Chairman, Chief Executive Officer, and Managing Director of the company since April 2023. Prior to this, he served as Chief Medical Officer at Cellectar Biosciences, Inc. Mr. John also served as the Chief Medical Officer at Cellectar Biosciences.
Mr Karen Krumeich
Chief Financial Officer Senior ManagementMs. Karen Krumeich has been the Chief Financial Officer of the company since 2022. Prior to this, she served as the Chief Financial Officer at Soligenix Inc, and Theravectys, Inc.
Anna Sandham
Secretary Senior ManagementEbru Davidson
Director Non Executive BoardBryce Carmine
Director Non Executive BoardStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer